| payload |
{"created_at":"2026-04-07T03:18:43.308 {"created_at":"2026-04-07T03:18:43.308311+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:57e4ad942ab86ca5","evidence_event_ids":["evt_fc2c96ec260a"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","as_of":"2026-04-07T03:18:43.308311+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","company":"Vir Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","article_chars":2006,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_2b6973232c90f5f7","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","content_type":"text/plain","enriched_at":"2026-04-07T08:01:56.382883+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt","source_event_id":"evt_fc2c96ec260a","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"a87590aad4ad6495","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-06","2026-02-23","2026-02-24"],"entities":[{"asset_class":"equity","name":"Vir Biotechnology, Inc.","relevance":"issuer","symbol":"VIR","type":"company"}],"event_type":"listing","information_gaps":["No specific details on the number of shares sold or the total value of the transaction."],"key_facts":["Form 144 filed on April 6, 2026","Reporting owner: Marianne De Backer","Transaction includes sales to cover tax obligations from vested equity awards."],"numeric_claims":[],"primary_claim":"Vir Biotechnology, Inc. filed Form 144 on April 6, 2026.","relevance_score":0.7,"sentiment":"neutral","source_quality":"medium","summary":"Vir Biotechnology, Inc. filed Form 144 on April 6, 2026, indicating a transaction involving restricted stock vesting and sales to cover tax obligations.","topics":["SEC filing","stock transaction","restricted stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260406","ticker":"VIR","tickers":["VIR"],"title":"VIR filed 144","url":"https://www.sec.gov/Archives/edgar/data/1706431/0001959173-26-002789.txt"}}... |